Key result
Influenza and SARS-CoV-2 link to greater symptom severity in athletes, with influenza showing ~88% severe illness.
Why the study?
To describe the etiology of acute respiratory infections in athletic individuals and identify differences in clinical presentation, potential multi-organ involvement, and illness classification across common pathogen groups.
Do clinical manifestations and illness severity differ among common viral respiratory pathogens in athletic individuals?
Observational (n=116)
Do clinical manifestations and illness severity differ among common viral respiratory pathogens in athletic individuals?
Influenza and SARS-CoV-2 cause more severe and systemic symptoms than rhinovirus and common coronaviruses in athletes, which may inform return-to-sport risk assessment.
Informs etiology-aware risk assessment in athletes; leaves open need for prospective validation of symptom associations.
Objectives The aims of this study were to describe the etiology of acute respiratory infections (ARinf) in athletic individuals, and to identify differences in the clinical presentation, evidence of possible multi-organ involvement, and illness classification between common pathogen groups.Methods One-hundred-and-sixteen cases of confirmed ARinf in athletic individuals were evaluated ≤5 days of the onset of an ARinf. Nasopharyngeal swab multiplex PCR testing was performed to identify a causative pathogen. Symptomatology, clinical examination findings, results of selected blood tests, and the clinical syndrome and illness severity classifications were compared between four common pathogen groups.Results The etiologies of ARinf in this cohort were: rhinovirus = 34(29%), influenza = 17(15%), SARS-CoV-2 = 15(13%), common coronavirus = 13(11%), ‘unidentified’ = 16(14%), ‘dual pathogen’ = 9(8%), and ‘other’ = 12(10%). Clinical presentation differed among the four common pathogen groups as follows: Influenza had more total symptoms, lower respiratory & regional symptoms, and systemic & non-respiratory symptoms than rhinovirus (p ≤ 0.002) and common coronavirus (p < 0.05). Influenza and SARS-CoV-2 had higher total symptoms and systemic & non-respiratory symptom severity scores than rhinovirus (p ≤ 0.0006 and p < 0.03 respectively) and common coronavirus (p ≤ 0.03 and p = 0.02 respectively). Evidence of other non-respiratory organ involvement on clinical examination was highest for influenza (53%). Illness classification for pathogen groups differed: common coronavirus had the highest percentage (%) of rhinitis-like (‘common cold’) illnesses (69%), and influenza had the highest % of ‘flu-like’ illnesses (82%). Influenza had the highest % of severe illnesses (88%) and common coronavirus the lowest (31%). 41% of rhinovirus presented with severe illness.Conclusion Influenza and SARS-CoV-2 had greater number and severity of symptoms than rhinovirus and common coronavirus. Among the four common pathogen groups, influenza had the highest percentage of abnormal clinical examination and serological findings and severe illnesses. Knowledge of the causative pathogen and the clinical presentation may add value to the risk assessment and guide clinical decision-making in return-to-sport following ARinf in athletic individuals.
No takes yet. Share an insight, caveat, or question.
Jooste et al. (2025) conducted an observational in Acute respiratory infections in athletes (n=116). Viral respiratory pathogens (Influenza, SARS-CoV-2, Rhinovirus, Common coronavirus) vs. Comparison among pathogen groups was evaluated on Clinical presentation, multi-organ involvement, and illness classification. Influenza and SARS-CoV-2 caused greater symptom severity than rhinovirus and common coronavirus in athletes, with influenza having the highest rate of severe illness (88%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: